Intrinsic Value of S&P & Nasdaq Contact Us

The Valens Company Inc. VLNS.TO TSX

Toronto Stock Exchan • Healthcare • Drug Manufacturers - Specialty & Generic • CA • CAD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

The Valens Company Inc. (VLNS.TO) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 28/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
30/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
14/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — VLNS.TO

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.55
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.15
Book Value / Share$0.00
Revenue / Share$1.84
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2011 $-0.36 $0.00 $-86.05K -
2012 $-4.25 $0.00 $-1.72M -
2013 $-2.32 $0.00 $-1.45M -
2015 $-0.37 $132.52K $-591.8K -446.6%
2016 $-0.49 $105K $-8.33M -7935.8%
2017 $-0.25 $40.72K $-4.63M -11359.6%
2018 $-0.65 $51.53K $-15.91M -30881.1%
2019 $-0.18 $58.11M $-6.54M -11.2%
2020 $-0.49 $83.78M $-20.68M -24.7%
2021 $-1.15 $78.18M $-49.03M -62.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message